Wall Street analysts expect Acadia Healthcare Company, Inc. (NASDAQ:ACHC) to announce earnings per share (EPS) of $0.55 for the current fiscal quarter, according to Zacks. Eight analysts have issued estimates for Acadia Healthcare’s earnings, with estimates ranging from $0.54 to $0.56. Acadia Healthcare posted earnings of $0.59 per share in the same quarter last year, which suggests a negative year-over-year growth rate of 6.8%. The business is scheduled to announce its next quarterly earnings results on Thursday, February 22nd.
According to Zacks, analysts expect that Acadia Healthcare will report full year earnings of $2.23 per share for the current year, with EPS estimates ranging from $2.20 to $2.25. For the next fiscal year, analysts expect that the company will post earnings of $2.44 per share, with EPS estimates ranging from $2.27 to $2.63. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that that provide coverage for Acadia Healthcare.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.07). The business had revenue of $716.70 million for the quarter, compared to the consensus estimate of $728.86 million. Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The firm’s revenue for the quarter was down 2.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.58 EPS.
ACHC has been the topic of a number of recent research reports. Zacks Investment Research downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, October 2nd. Jefferies Group set a $60.00 target price on shares of Acadia Healthcare and gave the stock a “buy” rating in a report on Wednesday, October 11th. BMO Capital Markets assumed coverage on shares of Acadia Healthcare in a report on Monday, October 16th. They issued an “outperform” rating and a $52.00 target price on the stock. KeyCorp reiterated a “buy” rating and issued a $59.00 target price on shares of Acadia Healthcare in a report on Friday, October 20th. Finally, Cantor Fitzgerald dropped their target price on shares of Acadia Healthcare from $48.00 to $39.00 and set a “neutral” rating on the stock in a report on Tuesday, October 24th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and eight have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $44.17.
Acadia Healthcare (ACHC) traded up $0.79 during trading on Friday, hitting $34.01. 1,463,346 shares of the stock were exchanged, compared to its average volume of 1,406,462. The company has a market cap of $2,910.00, a P/E ratio of 17.35, a P/E/G ratio of 1.13 and a beta of 0.90. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 1.30. Acadia Healthcare has a fifty-two week low of $26.92 and a fifty-two week high of $54.34.
In other news, Director Reeve B. Waud sold 100,000 shares of Acadia Healthcare stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $31.80, for a total transaction of $3,180,000.00. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 11.10% of the stock is currently owned by insiders.
Hedge funds and other institutional investors have recently made changes to their positions in the business. Schwab Charles Investment Management Inc. increased its stake in Acadia Healthcare by 13.8% in the second quarter. Schwab Charles Investment Management Inc. now owns 330,515 shares of the company’s stock valued at $16,321,000 after purchasing an additional 40,119 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Acadia Healthcare by 11.1% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock valued at $134,000 after buying an additional 270 shares during the period. Alliancebernstein L.P. boosted its holdings in shares of Acadia Healthcare by 66.0% in the second quarter. Alliancebernstein L.P. now owns 65,453 shares of the company’s stock valued at $3,232,000 after buying an additional 26,023 shares during the period. Riverhead Capital Management LLC acquired a new position in shares of Acadia Healthcare in the second quarter valued at approximately $209,000. Finally, Teachers Advisors LLC boosted its holdings in shares of Acadia Healthcare by 3.6% in the second quarter. Teachers Advisors LLC now owns 386,935 shares of the company’s stock valued at $19,107,000 after buying an additional 13,364 shares during the period.
WARNING: “Zacks: Analysts Anticipate Acadia Healthcare Company, Inc. (ACHC) to Announce $0.55 Earnings Per Share” was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://ledgergazette.com/2018/01/19/zacks-analysts-anticipate-acadia-healthcare-company-inc-achc-to-announce-0-55-earnings-per-share.html.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.